Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity
出版年份 2011 全文链接
标题
Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity
作者
关键词
-
出版物
MEDICAL ONCOLOGY
Volume 29, Issue 3, Pages 2159-2165
出版商
Springer Nature
发表日期
2011-09-23
DOI
10.1007/s12032-011-0065-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bevacizumab potentiates chemotherapeutic effect on T-leukemia/lymphoma cells by direct action on tumor endothelial cells
- (2011) L. Wang et al. HAEMATOLOGICA
- Pericytes and vessel maturation during tumor angiogenesis and metastasis
- (2010) Ahmad Raza et al. AMERICAN JOURNAL OF HEMATOLOGY
- Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma
- (2010) Jia Ruan et al. CANCER
- Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma
- (2010) Richard R. Furman et al. CANCER
- Epstein–Barr virus as a prognostic factor inde novonodal diffuse large B-cell lymphoma
- (2010) Domingo Morales et al. LEUKEMIA & LYMPHOMA
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- Epstein-Barr virus–positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype
- (2009) Sarah E. Gibson et al. HUMAN PATHOLOGY
- Epstein-Barr virus–positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations
- (2009) Sylvia Hoeller et al. HUMAN PATHOLOGY
- Epstein-Barr virus positive diffuse large B-cell lymphoma of the elderly
- (2009) Hannah H. Wong et al. LEUKEMIA & LYMPHOMA
- A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108
- (2009) Alison T. Stopeck et al. LEUKEMIA & LYMPHOMA
- Pronostic significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature
- (2009) Semra Paydas et al. LEUKEMIA RESEARCH
- Anti-angiogenic strategies will be a revolution in lymphoma?
- (2009) Semra Paydas LEUKEMIA RESEARCH
- Age-related EBV-associated B-cell lymphoproliferative disorders: Diagnostic approach to a newly recognized clinicopathological entity
- (2009) Yoshie Shimoyama et al. PATHOLOGY INTERNATIONAL
- Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: Correlation with clinicopathological features and prognosis
- (2009) Zhi Li et al. PATHOLOGY RESEARCH AND PRACTICE
- mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)
- (2008) Shernan G. Holtan et al. AMERICAN JOURNAL OF HEMATOLOGY
- Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma
- (2008) J. Ruan et al. ANNALS OF ONCOLOGY
- Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B
- (2008) Sonali M. Smith et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: Low-dose metronomic, multidrug therapy
- (2008) Morton Coleman et al. CANCER
- Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas
- (2008) Semra Paydas et al. LEUKEMIA RESEARCH
- Homage to Judah Folkman
- (2008) B. A. Chabner et al. ONCOLOGIST
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started